The Effect of Liposomal Bupivacaine on Post Operative Pain and Narcotic Use After Bariatric Surgery

NCT03196505 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

231

Enrollment

OTHER

Sponsor class

Conditions

Bariatric Surgery Candidate
Pain, Postoperative

Interventions

DRUG: Exparel 266 MG Per 20 ML Injection
DRUG: Bupivacaine

Sponsor

University of California, San Francisco